-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Palisade Bio with Outperform Rating, Announces Price Target of $6

Benzinga·10/09/2026 11:13:02
Raymond James analyst Thomas Deal initiates coverage on Palisade Bio (NASDAQ:PALI) with a Outperform rating and announces Price Target of $6.